HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wojciech Kamysz Selected Research

Tachypleus tridentatus tachyplesin peptide

12/2008Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.
1/2008Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
12/2007The antimicrobial peptide tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wojciech Kamysz Research Topics

Disease

37Infections
11/2021 - 11/2002
14Sepsis (Septicemia)
08/2021 - 07/2002
7Septic Shock (Toxic Shock Syndrome)
01/2008 - 01/2002
4Wounds and Injuries (Trauma)
10/2021 - 04/2008
4Necrosis
01/2021 - 01/2002
4Hemolysis
01/2020 - 02/2010
4Atopic Dermatitis (Atopic Eczema)
02/2018 - 05/2016
4Neoplasms (Cancer)
11/2016 - 06/2010
3Inflammation (Inflammations)
01/2022 - 10/2013
3Hypoxia (Hypoxemia)
01/2017 - 04/2015
2Wound Infection (Wound Infections)
10/2021 - 10/2013
2Mycoses (Diseases, Fungus)
11/2020 - 04/2014
2Surgical Wound
12/2019 - 04/2008
2Staphylococcal Infections
10/2019 - 06/2007
2Eye Infections
01/2019 - 10/2016
2Peritonitis
01/2017 - 01/2008
2Catheter-Related Infections
10/2016 - 06/2006
2Staphylococcal Skin Infections
09/2013 - 08/2012
2Melanoma (Melanoma, Malignant)
06/2010 - 09/2005
2Bacteremia
11/2007 - 06/2006
2Body Weight (Weight, Body)
07/2004 - 07/2002
1Periodontitis
01/2022
1Vulvovaginal Candidiasis
08/2021
1Colitis
02/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2021
1Pyoderma
03/2020
1Rupture
12/2019
1Candidemia
01/2018
1Bacterial Infections (Bacterial Infection)
12/2017

Drug/Important Bio-Agent (IBA)

22Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 07/2004
18Peptides (Polypeptides)IBA
09/2020 - 01/2002
14Antimicrobial PeptidesIBA
11/2021 - 01/2005
8temporinIBA
05/2016 - 11/2002
7LipopeptidesIBA
01/2020 - 01/2007
7pexigananIBA
01/2018 - 09/2004
7antimicrobial peptide IB-367 (iseganan)IBA
05/2014 - 11/2003
6ImipenemFDA Link
01/2017 - 07/2002
5Biocompatible Materials (Biomaterials)IBA
09/2020 - 08/2003
5Anti-Infective Agents (Microbicides)IBA
01/2020 - 11/2005
4EndotoxinsIBA
09/2006 - 01/2002
3OmigananIBA
08/2021 - 01/2006
3Messenger RNA (mRNA)IBA
01/2017 - 04/2015
3Adenosine Monophosphate (AMP)IBA
01/2017 - 12/2006
3KininsIBA
03/2015 - 12/2011
3Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
12/2011 - 12/2007
3Tachypleus tridentatus tachyplesin peptideIBA
12/2008 - 12/2007
3Linezolid (Zyvox)FDA Link
11/2007 - 08/2004
3Polyethylene Terephthalates (Polyethylene Terephthalate)IBA
06/2007 - 11/2002
3MagaininsIBA
11/2005 - 09/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2004 - 01/2002
2Pharmaceutical PreparationsIBA
01/2022 - 07/2010
2LipopolysaccharidesIBA
01/2022 - 11/2003
2CollagenIBA
10/2021 - 01/2017
2CathelicidinsIBA
10/2021 - 02/2021
2Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 04/2014
2Polystyrenes (Polystyrene)IBA
01/2019 - 01/2019
2Antimicrobial Cationic PeptidesIBA
06/2018 - 12/2016
2DaptomycinFDA Link
12/2017 - 10/2013
2Colistin (Coly-Mycin)FDA Link
01/2017 - 11/2005
2Proteins (Proteins, Gene)FDA Link
01/2017 - 08/2003
2Transcription Factors (Transcription Factor)IBA
03/2016 - 04/2015
2Biological ProductsIBA
03/2015 - 07/2010
2Methicillin (Metin)FDA Link
10/2013 - 11/2002
2BradykininIBA
10/2013 - 12/2011
2Clarithromycin (Biaxin)FDA LinkGeneric
12/2008 - 11/2005
2AgarIBA
06/2007 - 08/2003
2VancomycinFDA LinkGeneric
06/2007 - 11/2005
2HistatinsIBA
03/2005 - 07/2004
2GlycopeptidesIBA
08/2004 - 08/2003
2SolutionsIBA
07/2004 - 07/2002
2Sodium ChlorideFDA LinkGeneric
07/2004 - 07/2002
2Polymyxin B (Aerosporin)FDA LinkGeneric
07/2004 - 01/2002
1ChlorhexidineIBA
01/2022
1Metronidazole (Metric)FDA LinkGeneric
01/2022
1SilverIBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021
1AcidsIBA
02/2021
1Dextran SulfateIBA
02/2021
1Peroxidase (Myeloperoxidase)IBA
02/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Amino AcidsFDA Link
01/2020
1protegrin-1IBA
12/2019
1Liposomes (Liposome)IBA
12/2019
1Virulence Factors (Pathogenicity Factors)IBA
10/2019
1serum P-component (CIt)IBA
06/2018
1SuperantigensIBA
02/2018
1SaponinsIBA
01/2018
1Tigecycline (Tygacil)FDA Link
01/2018
1Fusidic Acid (Fucithalmic)IBA
12/2017
1Mupirocin (Bactroban)FDA LinkGeneric
12/2017
1MicroRNAs (MicroRNA)IBA
01/2017

Therapy/Procedure

10Therapeutics
02/2021 - 01/2007
7Punctures
01/2017 - 07/2002
7Ligation
01/2017 - 07/2002
4Intraperitoneal Injections
09/2004 - 07/2002
2Contact Lenses
01/2019 - 10/2016
2Central Venous Catheters
11/2007 - 06/2006
2Prostheses and Implants (Prosthesis)
06/2007 - 08/2003
1Catheters
01/2021
1Artificial Respiration (Mechanical Ventilation)
01/2019